Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 2/2012

01.02.2012 | Article

Clinical features of Clostridium difficile infection and molecular characterization of the isolated strains in a cohort of Danish hospitalized patients

verfasst von: L. M. Søes, I. Brock, S. Persson, J. Simonsen, K. E. Pribil Olsen, M. Kemp

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study was to compare clinical features of Clostridium difficile infection (CDI) to toxin gene profiles of the strains isolated from Danish hospitalized patients. C. difficile isolates were characterized by PCR based molecular typing methods including toxin gene profiling and analysis of deletions and truncating mutations in the toxin regulating gene tcdC. Clinical features were obtained by questionnaire. Thirty percent of the CDI cases were classified as community-acquired. Infection by C. difficile with genes encoding both toxin A, toxin B and the binary toxin was significantly associated with hospital-acquired/healthcare-associated CDI compared to community-acquired CDI. Significantly higher leukocyte counts and more severe clinical manifestations were observed in patients infected by C. difficile containing genes also encoding the binary toxin together with toxin A and B compared to patients infected by C. difficile harbouring only toxin A and B. In conclusion, infection by C. difficile harbouring genes encoding both toxin A, toxin B and the binary toxin were associated with hospital acquisition, higher leukocyte counts and severe clinical disease.
Literatur
1.
Zurück zum Zitat Kelly CP, Pothoulakis C, LaMont JT (1994) Clostridium difficile colitis. N Engl J Med 330(4):257–262PubMedCrossRef Kelly CP, Pothoulakis C, LaMont JT (1994) Clostridium difficile colitis. N Engl J Med 330(4):257–262PubMedCrossRef
2.
Zurück zum Zitat Bartlett JG, Gerding DN (2008) Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis 46(Suppl 1):S12–S18PubMedCrossRef Bartlett JG, Gerding DN (2008) Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis 46(Suppl 1):S12–S18PubMedCrossRef
3.
Zurück zum Zitat Bartlett JG (1994) Clostridium difficile: history of its role as an enteric pathogen and the current state of knowledge about the organism. Clin Infect Dis 18(Suppl 4):S265–S272PubMedCrossRef Bartlett JG (1994) Clostridium difficile: history of its role as an enteric pathogen and the current state of knowledge about the organism. Clin Infect Dis 18(Suppl 4):S265–S272PubMedCrossRef
4.
Zurück zum Zitat Popoff MR, Rubin EJ, Gill DM, Boquet P (1988) Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain. Infect Immun 56(9):2299–2306PubMed Popoff MR, Rubin EJ, Gill DM, Boquet P (1988) Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain. Infect Immun 56(9):2299–2306PubMed
5.
Zurück zum Zitat Perelle S, Gibert M, Bourlioux P, Corthier G, Popoff MR (1997) Production of a complete binary toxin (actin-specific ADP-ribosyltransferase) by Clostridium difficile CD196. Infect Immun 65(4):1402–1407PubMed Perelle S, Gibert M, Bourlioux P, Corthier G, Popoff MR (1997) Production of a complete binary toxin (actin-specific ADP-ribosyltransferase) by Clostridium difficile CD196. Infect Immun 65(4):1402–1407PubMed
6.
Zurück zum Zitat Barbut F, Gariazzo B, Bonne L, Lalande V, Burghoffer B, Luiuz R et al (2007) Clinical features of Clostridium difficile-associated infections and molecular characterization of strains: results of a retrospective study, 2000–2004. Infect Control Hosp Epidemiol 28(2):131–139PubMedCrossRef Barbut F, Gariazzo B, Bonne L, Lalande V, Burghoffer B, Luiuz R et al (2007) Clinical features of Clostridium difficile-associated infections and molecular characterization of strains: results of a retrospective study, 2000–2004. Infect Control Hosp Epidemiol 28(2):131–139PubMedCrossRef
7.
Zurück zum Zitat Warny M, Pepin J, Fang A, Killgore G, Thompson A, Brazier J et al (2005) Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366(9491):1079–1084PubMedCrossRef Warny M, Pepin J, Fang A, Killgore G, Thompson A, Brazier J et al (2005) Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366(9491):1079–1084PubMedCrossRef
8.
Zurück zum Zitat McEllistrem M, Carman R, Gerding D, Genheimer C, Zheng L (2005) A hospital outbreak of clostridium difficile disease associated with isolates carrying binary toxin genes. Clin Infect Dis 40(2):265–272PubMedCrossRef McEllistrem M, Carman R, Gerding D, Genheimer C, Zheng L (2005) A hospital outbreak of clostridium difficile disease associated with isolates carrying binary toxin genes. Clin Infect Dis 40(2):265–272PubMedCrossRef
9.
Zurück zum Zitat Goldenberg SD, French GL (2011) Lack of association of tcdC type and binary toxin status with disease severity and outcome in toxigenic Clostridium difficile. J Infect. March 17 [Epub ahead of print] Goldenberg SD, French GL (2011) Lack of association of tcdC type and binary toxin status with disease severity and outcome in toxigenic Clostridium difficile. J Infect. March 17 [Epub ahead of print]
10.
Zurück zum Zitat Murray R, Boyd D, Levett PN, Mulvey MR, Alfa MJ (2009) Truncation in the tcdC region of the Clostridium difficile PathLoc of clinical isolates does not predict increased biological activity of Toxin B or Toxin A. BMC Infect Dis 9:103PubMedCrossRef Murray R, Boyd D, Levett PN, Mulvey MR, Alfa MJ (2009) Truncation in the tcdC region of the Clostridium difficile PathLoc of clinical isolates does not predict increased biological activity of Toxin B or Toxin A. BMC Infect Dis 9:103PubMedCrossRef
11.
Zurück zum Zitat Goorhuis A, Bakker D, Corver J, Debast SB, Harmanus C, Notermans DW et al (2008) Emergence of clostridium difficile infection due to a new Hypervirulent strain, polymerase chain reaction Ribotype 078. Clin Infect Dis 47(9):1162–1170PubMedCrossRef Goorhuis A, Bakker D, Corver J, Debast SB, Harmanus C, Notermans DW et al (2008) Emergence of clostridium difficile infection due to a new Hypervirulent strain, polymerase chain reaction Ribotype 078. Clin Infect Dis 47(9):1162–1170PubMedCrossRef
12.
Zurück zum Zitat Persson S, Torpdahl M, Olsen KE (2008) New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection. Clin Microbiol Infect 14(11):1057–1064PubMedCrossRef Persson S, Torpdahl M, Olsen KE (2008) New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection. Clin Microbiol Infect 14(11):1057–1064PubMedCrossRef
13.
Zurück zum Zitat Kato H, Kato N, Katow S, Maegawa T, Nakamura S, Lyerly DM (1999) Deletions in the repeating sequences of the toxin A gene of toxin A-negative, toxin B-positive Clostridium difficile strains. FEMS Microbiol Lett 175(2):197–203PubMedCrossRef Kato H, Kato N, Katow S, Maegawa T, Nakamura S, Lyerly DM (1999) Deletions in the repeating sequences of the toxin A gene of toxin A-negative, toxin B-positive Clostridium difficile strains. FEMS Microbiol Lett 175(2):197–203PubMedCrossRef
14.
Zurück zum Zitat O'Neill GL, Ogunsola FT, Brazier JS, Duerden BI (1996) Modification of a PCR ribotyping method for application as a routine typing scheme for Clostridium difficile. Anaerobe 2(4):205–209CrossRef O'Neill GL, Ogunsola FT, Brazier JS, Duerden BI (1996) Modification of a PCR ribotyping method for application as a routine typing scheme for Clostridium difficile. Anaerobe 2(4):205–209CrossRef
15.
Zurück zum Zitat Stubbs SL, Brazier JS, O'Neill GL, Duerden BI (1999) PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol 37(2):461–463PubMed Stubbs SL, Brazier JS, O'Neill GL, Duerden BI (1999) PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol 37(2):461–463PubMed
16.
Zurück zum Zitat McFarland LV, Surawicz CM, Stamm WE (1990) Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis 162(3):678–684PubMedCrossRef McFarland LV, Surawicz CM, Stamm WE (1990) Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis 162(3):678–684PubMedCrossRef
17.
Zurück zum Zitat Sunenshine RH, McDonald LC (2006) Clostridium difficile-associated disease: new challenges from an established pathogen. Cleve Clin J Med 73(2):187–197PubMedCrossRef Sunenshine RH, McDonald LC (2006) Clostridium difficile-associated disease: new challenges from an established pathogen. Cleve Clin J Med 73(2):187–197PubMedCrossRef
18.
Zurück zum Zitat Hurley BW, Nguyen CC (2002) The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea. Arch Intern Med 162(19):2177–2184PubMedCrossRef Hurley BW, Nguyen CC (2002) The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea. Arch Intern Med 162(19):2177–2184PubMedCrossRef
19.
Zurück zum Zitat Tedesco FJ (1982) Pseudomembranous colitis: pathogenesis and therapy. Med Clin North Am 66(3):655–664PubMed Tedesco FJ (1982) Pseudomembranous colitis: pathogenesis and therapy. Med Clin North Am 66(3):655–664PubMed
20.
Zurück zum Zitat Bauer MP, Kuijper EJ, van Dissel JT (2009) European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect 15(12):1067–1079PubMedCrossRef Bauer MP, Kuijper EJ, van Dissel JT (2009) European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect 15(12):1067–1079PubMedCrossRef
21.
Zurück zum Zitat Paltansing S, van den Berg RJ, Guseinova RA, Visser CE, Van DV, Kuijper EJ (2007) Characteristics and incidence of Clostridium difficile-associated disease in The Netherlands 2005. Clin Microbiol Infect 13(11):1058–1064PubMedCrossRef Paltansing S, van den Berg RJ, Guseinova RA, Visser CE, Van DV, Kuijper EJ (2007) Characteristics and incidence of Clostridium difficile-associated disease in The Netherlands 2005. Clin Microbiol Infect 13(11):1058–1064PubMedCrossRef
22.
Zurück zum Zitat Geric B, Carman RJ, Rupnik M, Genheimer CW, Sambol SP, Lyerly DM et al (2006) Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters. J Infect Dis 193(8):1143–1150PubMedCrossRef Geric B, Carman RJ, Rupnik M, Genheimer CW, Sambol SP, Lyerly DM et al (2006) Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters. J Infect Dis 193(8):1143–1150PubMedCrossRef
23.
Zurück zum Zitat Goncalves C, Decre D, Barbut F, Burghoffer B, Petit JC (2004) Prevalence and characterization of a binary toxin (actin-specific ADP-ribosyltransferase) from Clostridium difficile. J Clin Microbiol 42(5):1933–1939PubMedCrossRef Goncalves C, Decre D, Barbut F, Burghoffer B, Petit JC (2004) Prevalence and characterization of a binary toxin (actin-specific ADP-ribosyltransferase) from Clostridium difficile. J Clin Microbiol 42(5):1933–1939PubMedCrossRef
24.
Zurück zum Zitat Stubbs S, Rupnik M, Gibert M, Brazier J, Duerden B, Popoff M (2000) Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile. FEMS Microbiol Lett 186(2):307–312PubMedCrossRef Stubbs S, Rupnik M, Gibert M, Brazier J, Duerden B, Popoff M (2000) Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile. FEMS Microbiol Lett 186(2):307–312PubMedCrossRef
25.
Zurück zum Zitat Bolton RP, Tait SK, Dear PR, Losowsky MS (1984) Asymptomatic neonatal colonisation by Clostridium difficile. Arch Dis Child 59(5):466–472PubMedCrossRef Bolton RP, Tait SK, Dear PR, Losowsky MS (1984) Asymptomatic neonatal colonisation by Clostridium difficile. Arch Dis Child 59(5):466–472PubMedCrossRef
26.
Zurück zum Zitat Viscidi R, Willey S, Bartlett JG (1981) Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. Gastroenterology 81(1):5–9PubMed Viscidi R, Willey S, Bartlett JG (1981) Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. Gastroenterology 81(1):5–9PubMed
27.
Zurück zum Zitat Donta ST, Myers MG (1982) Clostridium difficile toxin in asymptomatic neonates. J Pediatr 100(3):431–434PubMedCrossRef Donta ST, Myers MG (1982) Clostridium difficile toxin in asymptomatic neonates. J Pediatr 100(3):431–434PubMedCrossRef
28.
Zurück zum Zitat Vesikari T, Isolauri E, Maki M, Gronroos P (1984) Clostridium difficile in young children. Association with antibiotic usage. Acta Paediatr Scand 73(1):86–91PubMedCrossRef Vesikari T, Isolauri E, Maki M, Gronroos P (1984) Clostridium difficile in young children. Association with antibiotic usage. Acta Paediatr Scand 73(1):86–91PubMedCrossRef
29.
Zurück zum Zitat Klein EJ, Boster DR, Stapp JR, Wells JG, Qin X, Clausen CR et al (2006) Diarrhea etiology in a children's hospital emergency department: a prospective cohort study. Clin Infect Dis 43(7):807–813PubMedCrossRef Klein EJ, Boster DR, Stapp JR, Wells JG, Qin X, Clausen CR et al (2006) Diarrhea etiology in a children's hospital emergency department: a prospective cohort study. Clin Infect Dis 43(7):807–813PubMedCrossRef
30.
Zurück zum Zitat Kim J, Smathers SA, Prasad P, Leckerman KH, Coffin S, Zaoutis T (2008) Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001–2006. Pediatrics 122(6):1266–1270PubMedCrossRef Kim J, Smathers SA, Prasad P, Leckerman KH, Coffin S, Zaoutis T (2008) Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001–2006. Pediatrics 122(6):1266–1270PubMedCrossRef
31.
Zurück zum Zitat Karlstrom O, Fryklund B, Tullus K, Burman LG (1998) A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. The Swedish C. difficile study group. Clin Infect Dis 26(1):141–145PubMedCrossRef Karlstrom O, Fryklund B, Tullus K, Burman LG (1998) A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. The Swedish C. difficile study group. Clin Infect Dis 26(1):141–145PubMedCrossRef
32.
Zurück zum Zitat Noren T, Akerlund T, Back E, Sjoberg L, Persson I, Alriksson I et al (2004) Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county. J Clin Microbiol 42(8):3635–3643PubMedCrossRef Noren T, Akerlund T, Back E, Sjoberg L, Persson I, Alriksson I et al (2004) Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county. J Clin Microbiol 42(8):3635–3643PubMedCrossRef
33.
Zurück zum Zitat Kyne L, Merry C, O'Connell B, Keane C, O'Neill D (1998) Community-acquired Clostridium difficile infection. J Infect 36(3):287–288PubMedCrossRef Kyne L, Merry C, O'Connell B, Keane C, O'Neill D (1998) Community-acquired Clostridium difficile infection. J Infect 36(3):287–288PubMedCrossRef
34.
Zurück zum Zitat Wilcox MH, Mooney L, Bendall R, Settle CD, Fawley WN (2008) A case-control study of community-associated Clostridium difficile infection. J Antimicrob Chemother 62(2):388–396PubMedCrossRef Wilcox MH, Mooney L, Bendall R, Settle CD, Fawley WN (2008) A case-control study of community-associated Clostridium difficile infection. J Antimicrob Chemother 62(2):388–396PubMedCrossRef
35.
Zurück zum Zitat Verdoorn BP, Orenstein R, Rosenblatt JE, Sloan LM, Schleck CD, Harmsen WS et al (2010) High prevalence of tcdC deletion-carrying Clostridium difficile and lack of association with disease severity. Diagn Microbiol Infect Dis 66(1):24–28PubMedCrossRef Verdoorn BP, Orenstein R, Rosenblatt JE, Sloan LM, Schleck CD, Harmsen WS et al (2010) High prevalence of tcdC deletion-carrying Clostridium difficile and lack of association with disease severity. Diagn Microbiol Infect Dis 66(1):24–28PubMedCrossRef
Metadaten
Titel
Clinical features of Clostridium difficile infection and molecular characterization of the isolated strains in a cohort of Danish hospitalized patients
verfasst von
L. M. Søes
I. Brock
S. Persson
J. Simonsen
K. E. Pribil Olsen
M. Kemp
Publikationsdatum
01.02.2012
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 2/2012
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-011-1292-0

Weitere Artikel der Ausgabe 2/2012

European Journal of Clinical Microbiology & Infectious Diseases 2/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Ist Fasten vor Koronarinterventionen wirklich nötig?

Wenn Eingriffe wie eine Koronarangiografie oder eine Koronarangioplastie anstehen, wird häufig empfohlen, in den Stunden zuvor nüchtern zu bleiben. Ein französisches Forscherteam hat diese Maßnahme hinterfragt.

Typ-2-Diabetes: Ernährungsunsicherheit vervierfacht Risiko für schwere Hypoglykämien

04.06.2024 Typ-2-Diabetes Nachrichten

Wenn ältere Menschen mit Typ-2-Diabetes Schwierigkeiten beim Beschaffen und Zubereiten von Mahlzeiten haben, geht dies mit einem deutlich gesteigerten Risiko für schwere Hypoglykämien einher.

Mehr Brustkrebs, aber weniger andere gynäkologische Tumoren mit Levonorgestrel-IUS

04.06.2024 Levonorgestrel Nachrichten

Unter Frauen, die ein Levonorgestrel-freisetzendes intrauterines System (IUS) verwenden, ist die Brustkrebsrate um 13% erhöht. Dafür kommt es deutlich seltener zu Endometrium-, Zervix- und Ovarialkarzinomen.

GLP-1-Agonist Semaglutid wirkt kardio- und nephroprotektiv

03.06.2024 Semaglutid Nachrichten

Der GLP-1-Agonist Semaglutid hat in der FLOW-Studie bewiesen, dass sich damit die Progression chronischer Nierenerkrankungen bei Patienten mit Typ-2-Diabetes bremsen lässt. Auch in kardiovaskulärer Hinsicht war die Therapie erfolgreich.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.